Patent · US Active

Subcutaneous formulations of anti-CD38 antibodies and their uses

US11732051B2 · kind B2 · utility

3Cited by
26References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 13, 2020
Grant dateAug 22, 2023
Priority date—
Expiry dateFeb 13, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.